Phibro Animal Company Insiders
| PAHC Stock | USD 52.26 0.99 1.93% |
Phibro Animal's insiders are aggressively selling. The analysis of insiders' sentiment of trading Phibro Animal Health stock suggests that all insiders are panicking at this time. Phibro Animal employs about 2.5 K people. The company is managed by 19 executives with a total tenure of roughly 87 years, averaging almost 4.0 years of service per executive, having 130.26 employees per reported executive.
| Jack Bendheim Chairman Chairman of the Board and Presidentident, CEO |
| Thomas Dagger President Senior Vice President General Counsel, Corporate Secretary |
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
| 2026-02-11 | Jack Bendheim | Disposed 14184 @ 51.62 | View | ||
| 2026-02-10 | Jack Bendheim | Disposed 58014 @ 51.81 | View | ||
| 2026-02-05 | Jack Bendheim | Disposed 110842 @ 48.38 | View | ||
| 2026-02-04 | Jack Bendheim | Disposed 3520 @ 41.15 | View | ||
| 2026-02-03 | Jack Bendheim | Disposed 9660 @ 41.47 | View | ||
| 2026-01-30 | Jack Bendheim | Disposed 6693 @ 40.09 | View | ||
| 2026-01-29 | Jack Bendheim | Disposed 6772 @ 40.12 | View | ||
| 2026-01-23 | Jack Bendheim | Disposed 1235 @ 40.55 | View | ||
| 2026-01-22 | Jack Bendheim | Disposed 13158 @ 41.98 | View | ||
| 2026-01-21 | Jack Bendheim | Disposed 14687 @ 41.68 | View | ||
| 2026-01-15 | Jack Bendheim | Disposed 2932 @ 40.02 | View | ||
| 2026-01-14 | Jack Bendheim | Disposed 3651 @ 40.53 | View | ||
| 2026-01-13 | Jack Bendheim | Disposed 7551 @ 40.32 | View | ||
| 2026-01-09 | Jack Bendheim | Disposed 213 @ 40.16 | View | ||
| 2026-01-07 | Jack Bendheim | Disposed 328 @ 40.09 | View | ||
| 2025-12-11 | Jack Bendheim | Disposed 5752 @ 40.93 | View | ||
| 2025-12-09 | Jack Bendheim | Disposed 1288 @ 40.19 | View | ||
| 2025-12-08 | Jack Bendheim | Disposed 3520 @ 40.06 | View | ||
| 2025-12-03 | Jack Bendheim | Disposed 3520 @ 40.77 | View | ||
| 2025-11-26 | Jack Bendheim | Disposed 5280 @ 44.02 | View |
Monitoring Phibro Animal's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. Phibro Animal's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Phibro Animal's future performance. Based on our forecasts, it is anticipated that Phibro will maintain a workforce of about 2480 employees by March 2026.Phibro Animal Management Team Effectiveness
The company has return on total asset (ROA) of 0.0834 % which means that it generated a profit of $0.0834 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.318 %, meaning that it created $0.318 on every $100 dollars invested by stockholders. Phibro Animal's management efficiency ratios could be used to measure how well Phibro Animal manages its routine affairs as well as how well it operates its assets and liabilities. At present, Phibro Animal's Return On Equity is projected to slightly decrease based on the last few years of reporting. At present, Phibro Animal's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 73.8 M, whereas Non Currrent Assets Other are forecasted to decline to about 15.5 M.The current year's Net Income Applicable To Common Shares is expected to grow to about 42.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 35.2 M. Phibro Animal owns a total of 20.62 Million outstanding shares. The majority of Phibro Animal Health outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Phibro Animal Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Phibro Animal. Please pay attention to any change in the institutional holdings of Phibro Animal Health as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2002-09-30 | Previous Quarter 40.9 M | Current Value 41 M | Avarage Shares Outstanding 43.7 M | Quarterly Volatility 9.2 M |
Phibro Animal Workforce Comparison
Phibro Animal Health is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 348,469. Phibro Animal maintains roughly 2,475 in number of employees contributing less than 1% to equities under Health Care industry.
Phibro Animal Profit Margins
The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.22 | 0.28 |
|
| |||||
| Operating Profit Margin | 0.0614 | 0.0767 |
|
| |||||
| Pretax Profit Margin | 0.0276 | 0.0472 |
|
|
Phibro Animal Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Phibro Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Phibro Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Phibro Animal insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2026-03-01 | 0.1613 | 5 | 31 | 295,000 | 560,968 |
| 2025-12-01 | 0.122 | 5 | 41 | 175,000 | 351,474 |
| 2025-09-01 | 1.5 | 9 | 6 | 71,493 | 78,806 |
| 2025-03-01 | 2.0 | 2 | 1 | 35,000 | 30,000 |
| 2021-03-01 | 0.5 | 1 | 2 | 50,000 | 270,000 |
| 2019-03-01 | 0.25 | 8 | 32 | 41,340 | 116,010 |
| 2018-12-01 | 0.3333 | 1 | 3 | 10,000 | 20,000 |
| 2018-09-01 | 0.2969 | 19 | 64 | 435,440 | 739,920 |
| 2018-06-01 | 0.2045 | 9 | 44 | 551,060 | 566,120 |
| 2018-03-01 | 0.3158 | 18 | 57 | 399,227 | 732,229 |
| 2017-12-01 | 1.0 | 2 | 2 | 24,000 | 24,000 |
| 2017-09-01 | 0.5345 | 31 | 58 | 284,657 | 584,086 |
| 2017-06-01 | 0.3049 | 25 | 82 | 681,937 | 1,517,887 |
| 2017-03-01 | 0.5676 | 21 | 37 | 195,104 | 387,687 |
| 2016-12-01 | 0.5 | 5 | 10 | 9,338 | 18,676 |
| 2016-06-01 | 1.0 | 2 | 2 | 9,406 | 8,812 |
| 2016-03-01 | 0.3704 | 20 | 54 | 299,517 | 586,184 |
| 2015-12-01 | 0.2931 | 34 | 116 | 350,077 | 740,154 |
| 2015-09-01 | 0.2623 | 32 | 122 | 512,838 | 1,057,856 |
| 2015-06-01 | 0.2742 | 17 | 62 | 404,000 | 684,000 |
| 2015-03-01 | 0.375 | 3 | 8 | 12,000 | 143,644 |
| 2014-12-01 | 0.0435 | 1 | 23 | 4,000 | 946,361 |
| 2014-09-01 | 0.5 | 2 | 4 | 773,500 | 1,219,650 |
| 2014-06-01 | 1.35 | 27 | 20 | 106,800,505 | 196,390,934 |
Phibro Animal Notable Stakeholders
A Phibro Animal stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Phibro Animal often face trade-offs trying to please all of them. Phibro Animal's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Phibro Animal's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jack Bendheim | Chairman of the Board and Presidentident, CEO | Profile | |
| Ramon Fuenmayor | President Region | Profile | |
| Thomas Dagger | Senior Vice President General Counsel, Corporate Secretary | Profile | |
| Jonathan Bendheim | Director and President MACIE Region and General Manager of Israel Operations | Profile | |
| Rob Aukerman | President Region | Profile | |
| Todd Armstrong | President Region | Profile | |
| Daniel Bendheim | Executive Vice President Director, Corporate Strategy | Profile | |
| Michael Giambalvo | President Group | Profile | |
| Lisa Escudero | Senior Vice President-Human Resources | Profile | |
| Samson Li | President Region | Profile | |
| Daniel JD | Executive Director | Profile | |
| Mona Desai | VP Controller | Profile | |
| Anthony CPA | VP Treasurer | Profile | |
| Judith Weinstein | General VP | Profile | |
| Larry Miller | Chief Officer | Profile | |
| Damian Finio | Chief Officer | Profile | |
| Jean Filippi | Pres Region | Profile | |
| Richard Johnson | Interim Officer | Profile | |
| Glenn David | Chief Officer | Profile |
About Phibro Animal Management Performance
The success or failure of an entity such as Phibro Animal Health often depends on how effective the management is. Phibro Animal management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Phibro management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Phibro management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.03 | 0.02 | |
| Return On Capital Employed | 0.12 | 0.15 | |
| Return On Assets | 0.03 | 0.02 | |
| Return On Equity | 0.15 | 0.16 |
Please note, the presentation of Phibro Animal's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Phibro Animal's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Phibro Animal's management manipulating its earnings.
Phibro Animal Workforce Analysis
Traditionally, organizations such as Phibro Animal use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Phibro Animal within its industry.Phibro Animal Manpower Efficiency
Return on Phibro Animal Manpower
| Revenue Per Employee | 523.7K | |
| Revenue Per Executive | 68.2M | |
| Net Income Per Employee | 19.5K | |
| Net Income Per Executive | 2.5M | |
| Working Capital Per Employee | 208.9K | |
| Working Capital Per Executive | 27.2M |
Complementary Tools for Phibro Stock analysis
When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |